Start-Ups Swimming ...
Health Care: Drugs
Anika Therapeutics Inc. (ANIK: NASDAQ)
$14.06 0.03 | 0.21%
05/24/13 - 11:16 AM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 44.07M | 35.78M | 28.20M | 24.43M |
| Receivables | 21.46M | 17.31M | 14.82M | 11.83M |
| Inventories | 8.28M | 7.30M | 8.95M | 8.44M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 77.38M | 64.14M | 56.32M | 49.80M |
| Property, Plant & Equipment, Gross | 52.38M | 50.85M | 49.70M | 47.17M |
| Accumulated Depreciation & Depletion | 17.26M | 14.38M | 12.72M | 11.42M |
| Property, Plant & Equipment, Net | 35.11M | 36.47M | 36.98M | 35.75M |
| Intangibles | 20.33M | 23.15M | 25.76M | 33.58M |
| Other Non-Current Assets | 171.05K | 205.04K | 384.99K | 413.23K |
| Total Non-Current Assets | 64.68M | 68.71M | 72.61M | 80.90M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 142.07M | 132.84M | 128.94M | 130.70M |
| Accounts Payable | 2.34M | 4.30M | 9.69M | 6.37M |
| Short Term Debt | 1.60M | 1.60M | 1.60M | 1.60M |
| Other Current Liabilities | 1.80M | 450.48K | 0.00 | 0.00 |
| Total Current Liabilities | 14.45M | 14.54M | 19.37M | 16.53M |
| Long Term Debt | 8.00M | 9.60M | 11.20M | 12.80M |
| Deferred Income Taxes | 7.00M | 7.38M | 6.22M | 9.31M |
| Other Non-Current Liabilities | 3.69M | 6.57M | 6.96M | 9.92M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 18.69M | 23.54M | 24.38M | 32.02M |
| Total Liabilities | 33.14M | 38.08M | 43.75M | 48.56M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 108.93M | 94.76M | 85.19M | 82.14M |
| Common Par | 138.66K | 136.30K | 134.82K | 134.19K |
| Additional Paid In Capital | 65.43M | 63.44M | 61.82M | 60.54M |
| Cumulative Translation Adjustment | -2.65M | -3.07M | -2.55M | 0.00 |
| Retained Earnings | 46.01M | 34.25M | 25.79M | 21.47M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 116.93M | 104.36M | 96.39M | 94.94M |
| Total Equity | 108.93M | 94.76M | 85.19M | 82.14M |
| Total Liabilities & Stock Equity | 142.07M | 132.84M | 128.94M | 130.70M |
| Total Common Shares Outstanding | 13.87M | 13.63M | 13.48M | 13.42M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 13.26M | 13.06M | 12.62M | 11.39M |
| Diluted Weighted Shares Outstanding | 14.34M | 13.75M | 13.65M | 11.56M |
| Number of Employees | 129 | 129 | 114 | 133 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ANIK
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserTrade Growth
- Userbfab Portfolio 1
- Usersome mad buggers wall
- Usermjaquillard Portfolio 1
- UserJenaLoren Stocks
- Usermagic formula cws
Latest ANIK Headlines from TheStreet
- July Options Now Available For Anika Therapeutics (ANIK) 05.20.13 | 03:05 pm
- A Lower Stock Price Never Turns A Bad Company Into A Good One 03.27.13 | 06:03 am
- 5 Stocks Ready to Break Out 03.22.13 | 02:03 pm
- Anika Therapeutics' CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript 08.02.12 | 03:08 pm
- Anika Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.04.12 | 12:05 pm
- 8 Stocks Rising on Unusual Volume 04.09.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 04.02.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 03.21.12 | 02:03 pm
- Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.01.12 | 06:03 pm
- Anika Therapeutics Inc. Stock Upgraded (ANIK) 11.15.11 | 06:11 am
Press Releases for ANIK
- Anika Therapeutics To Present At The Canaccord Genuity Musculoskeletal Conference On March 19 - Business Wire 03.13.13 | 01:03 pm
- Anika Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.27.13 | 04:02 pm
- Anika Therapeutics Announces Date Of Fourth-Quarter And Year-End 2012 Financial Results Conference Call - Business Wire 02.14.13 | 08:02 am
- Anika Therapeutics Names Sylvia Cheung As Chief Financial Officer - Business Wire 01.22.13 | 08:01 am
- Anika Therapeutics Announces Monovisc PMA News - Business Wire 12.04.12 | 05:12 pm
- Anika Therapeutics Reports Third-Quarter Financial Results - Business Wire 10.30.12 | 04:10 pm
- Anika Therapeutics Postpones Release Of Third-Quarter 2012 Financial Results To October 30 - Business Wire 10.29.12 | 01:10 pm
- Anika Therapeutics Announces Date Of Third-Quarter 2012 Financial Results Conference Call - Business Wire 10.18.12 | 07:10 am
- Anika Therapeutics Reports Record Second Quarter Revenue And Earnings - Business Wire 08.01.12 | 04:08 pm
- Anika Therapeutics Announces Date Of Second-Quarter 2012 Financial Results Conference Call - Business Wire 07.19.12 | 03:07 pm
Partner Headlines for ANIK
- Morning Market Losers - Benzinga 12.05.12 | 09:12 am
- 3 Liquid Biotech Stocks With Impressive Growth Projections - Seeking Alpha 08.12.12 | 09:08 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 06.04.12 | 09:06 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.30.12 | 09:05 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 05.25.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.23.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.17.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.10.12 | 09:05 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.08.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 04.25.12 | 09:04 am
